Pasithea Therapeutics (KTTA) Non Operating Income (2021 - 2026)
Pasithea Therapeutics' Non Operating Income was $439,430 in Q2 2026, up 363.8% from $94,742 a year earlier but down 78.1% from the prior quarter.
Pasithea Therapeutics (KTTA) Non Operating Income (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pasithea Therapeutics' Non Operating Income was $2.66 million through Jun 30, 2026, up 793.1% year-over-year; for FY2025, it came in at $429,612, up 24.4% from FY2024.
- Non Operating Income shows a four-year compound annual growth rate of -34.5% (FY2021 to FY2025).
- In earlier years, Non Operating Income was $345,378 in FY2024 (-26.8%), $471,613 in FY2023 and $2.33 million in FY2021.
- Quarterly Non Operating Income has moved between -$335,317 (Q3 2022) and $2.59 million (Q4 2021) over five years.
- Compared with a year earlier, Non Operating Income was higher in three of the last six quarters, with growth averaging 49.8%.
- The best year-over-year quarter for Non Operating Income over five years was Q2 2026 (growth of 363.8%); the worst was Q3 2024 (a decline of 97.3%).
- Per Business Quant data, KTTA's Non Operating Income in the three quarters before Q2 2026 was $2.01 million (Q1 2026), $145,294 (Q4 2025) and $72,635 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Pasithea Therapeutics | 16.37 Mn | 16.37 Mn | - | 439,430.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 439,430.00 |
| Mar 31, 2026 | 2.01 Mn |
| Dec 31, 2025 | 145,294.00 |
| Sep 30, 2025 | 72,635.00 |
| Jun 30, 2025 | 94,742.00 |
| Mar 31, 2025 | 116,941.00 |
| Dec 31, 2024 | 81,889.00 |
| Sep 30, 2024 | 4,770.00 |
| Jun 30, 2024 | 78,785.00 |
| Mar 31, 2024 | 179,934.00 |
| Dec 31, 2023 | 117,518.00 |
| Sep 30, 2023 | 176,736.00 |
| Jun 30, 2023 | 230,617.00 |
| Mar 31, 2023 | -53,258.00 |
| Sep 30, 2022 | -335,317.00 |
| Jun 30, 2022 | 421,700.00 |
| Mar 31, 2022 | 830,297.00 |
| Dec 31, 2021 | 2.59 Mn |
| Sep 30, 2021 | -252,508.00 |
Pasithea Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=KTTA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "KTTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=KTTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();